Cite
HARVARD Citation
Cecchin, E. et al. (2020). Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy. Radiotherapy and oncology. pp. 30-37. [Online].